-
1Academic Journal
-
2Academic Journal
-
3Academic Journal
Source: Высшая школа: научные исследования.
Subject Terms: аутоиммунные заболевания, статистическая достоверность, структура, статистический анализ
-
4Academic Journal
Authors: Валерий Иванович Ларькин, Игорь Иванович Ларькин, Татьяна Аркадьевна Морозова, Степан Евгеньевич Аполлонов
Source: Мать и дитя в Кузбассе, Vol 25, Iss 4, Pp 65-71 (2024)
Subject Terms: рассеянный склероз, педиатрический рассеянный склероз, дебют, аутоиммунные заболевания, ожирение, коморбидность, Pediatrics, RJ1-570, Gynecology and obstetrics, RG1-991
File Description: electronic resource
-
5Academic Journal
Authors: Хайдаров , Н.К., Панжиева , Н.Н., Курбанов, Г.И.
Source: Eurasian Journal of Medical and Natural Sciences; Vol. 5 No. 9 (2025): Eurasian Journal of Medical and Natural Sciences; 92-99 ; Евразийский журнал медицинских и естественных наук; Том 5 № 9 (2025): Евразийский журнал медицинских и естественных наук; 92-99 ; Yevrosiyo tibbiyot va tabiiy fanlar jurnali; Jild 5 Nomeri 9 (2025): Евразийский журнал медицинских и естественных наук; 92-99 ; 2181-287X
Subject Terms: Фотобиомодуляция, миастения, низкоинтенсивная лазерная терапия, нейромышечная передача, аутоиммунные заболевания, Photobiomodulation, myasthenia gravis, low-level laser therapy, neuromuscular transmission, autoimmune diseases, Fotobiomodulyatsiya, miasteniya, past intensivlikdagi lazer terapiyasi, neyromushak uzatish, autoimmun kasalliklar
File Description: application/pdf
Availability: https://in-academy.uz/index.php/EJMNS/article/view/60768
-
6Academic Journal
Authors: Irina V. Karachentsova, Elena V. Sibirskaya, Ulyana A. Krainova, Veronika D. Mospan, Mariia Yu. Chernysheva, И. В. Караченцова, Е. В. Сибирская, У. А. Крайнова, В. Д. Моспан, М. Ю. Чернышева
Contributors: Not specified, Отсутствует
Source: Pediatric pharmacology; Том 22, № 3 (2025); 333-340 ; Педиатрическая фармакология; Том 22, № 3 (2025); 333-340 ; 2500-3089 ; 1727-5776
Subject Terms: клеточная терапия, autoimmune diseases, amenorrhea, estrogen deficiency, premature menopause, Addison’s disease, hypothyroidism, hormone replacement therapy, cell therapy, аутоиммунные заболевания, аменорея, дефицит эстрогенов, преждевременная менопауза, болезнь Аддисона, гипотиреоз, заместительная гормональная терапия
File Description: application/pdf
Relation: https://www.pedpharma.ru/jour/article/view/2648/1715; Vogt EC, Real FG, Husebye ES, et al. Premature menopause and autoimmune primary ovarian insufficiency in two international multicenter cohorts. Endocr Connect. 2022;11(5):e220024. doi: https://doi.org/10.1530/EC-22-0024; Табеева Г.И., Шамилова Н.Н., Жахур Н.А. и др. Преждевременная недостаточность яичников — загадка XXI века // Акушерство и гинекология. — 2013. — № 12. — С. 16–21.; Караченцова И.В., Сибирская Е.В., Хайруллина А.А. Преждевременная недостаточность яичников у пациенток с галактоземией // Педиатрическая фармакология. — 2024. — Т. 21. — № 2. — С. 119–125. — doi: https://doi.org/10.15690/pf.v21i2.2721; Komorowska B. Autoimmune premature ovarian failure. Prz Menopauzalny. 2016;15(4):210–214. doi: https://doi.org/10.5114/pm.2016.65666; Kirshenbaum M, Orvieto R. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal.j Assist Reprod Genet. 2019;36(11):2207–2215. doi: https://doi.org/10.1007/s10815-019-01572-0.; Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, et al. Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge. Int J Mol Sci. 2021;22(5):2594. doi: https://doi.org/10.3390/ijms22052594; Collins G, Patel B, Thakore S, Liu J. Primary Ovarian Insufficiency: Current Concepts. South Med J. 2017;110(3):147–153. doi: https://doi.org/10.14423/SMJ.0000000000000611; Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926–937. doi: https://doi.org/10.1093/humrep/dew027; Nelson LM, Bakalov VK. Mechanisms of follicular dysfunction in 46,XX spontaneous premature ovarian failure. Endocrinol Metab Clin North Am. 2003;32(3):613–637. doi: https://doi.org/10.1016/s0889-8529(03)00043-4; Ebrahimi M, Akbari Asbagh F. The role of autoimmunity in premature ovarian failure. Iran J Reprod Med. 2015;13(8):461–472.; Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gynecol Pathol. 1990;9(3):191–207. doi: https://doi.org/10.1097/00004347-199007000-00001; Sedmak DD, Hart WR, Tubbs RR. Autoimmune oophoritis: a histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate. Int J Gynecol Pathol. 1987;6(1):73.; Kobayashi M, Nakashima A, Yoshino O, et al. Decreased effector regulatory T cells and increased activated CD4+ T cells in premature ovarian insufficiency. Am J Reprod Immunol. 2019;81(6):e13125. doi: https://doi.org/10.1111/aji.13125; Xiong J, Tan R, Wang W, et al. Evaluation of CD4+CD25+FOXP3+ regulatory T cells and FOXP3 mRNA in premature ovarian insufficiency. Climacteric. 2020;23(3):267–272. doi: https://doi.org/10.1080/13697137.2019.1703938; Dal Pra C, Chen S, Furmaniak J, et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison’s disease. Eur J Endocrinol. 2003;148(5):565–570. doi: https://doi.org/10.1530/eje.0.1480565; Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev. 1997;18(1):107–134. doi: https://doi.org/10.1210/edrv.18.1.0291; Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod. 2002;17(8):2096–2100. doi: https://doi.org/10.1093/humrep/17.8.2096; Novosad JA, Kalantaridou SN, Tong ZB, Nelson LM. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health. 2003;3(1):2. doi: https://doi.org/10.1186/1472-6874-3-2; Monteleone P, Parrini D, Faviana P, et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol. 2011;66(2):108–114. doi: https://doi.org/10.1111/j.1600-0897.2010.00961.x; Dittrich R, Beckmann MW, Oppelt PG, et al. Thyroid hormone receptors and reproduction.j Reprod Immunol. 2011;90(1):58–66. doi: https://doi.org/10.1016/j.jri.2011.02.009; Medenica S, Garalejic E, Arsic B, et al. Follicular fluid thyroid autoantibodies, thyrotropin, free thyroxine levels and assisted reproductive technology outcome. PLoS One. 2018;13(10):e0206652. doi: https://doi.org/10.1371/journal.pone.0206652; Zhong YP, Ying Y, Wu HT, et al. Relationship between antithyroid antibody and pregnancy outcome following in vitro fertilization and embryo transfer. Int J Med Sci. 2012;9(2):121–125. doi: https://doi.org/10.7150/ijms.3467; Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure.j Clin Endocrinol Metab. 1987;64(3):494–500. doi: https://doi.org/10.1210/jcem-64-3-494; Reato G, Morlin L, Chen S, et al. Premature ovarian failure in patients with autoimmune Addison’s disease: clinical, genetic, and immunological evaluation.j Clin Endocrinol Metab. 2011;96(8):E1255–E1261. doi: https://doi.org/10.1210/jc.2011-0414; Meloni A, Willcox N, Meager A, et al. Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.j Clin Endocrinol Metab. 2012;97(4):1114–1124. doi: https://doi.org/10.1210/jc.2011-2461; Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol. 2010;6(5):270–277. doi: https://doi.org/10.1038/nrendo.2010.40; Szlendak-Sauer K, Jakubik D, Kunicki M, et al. Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI). Eur J Obstet Gynecol Reprod Biol. 2016;203:61–65. doi: https://doi.org/10.1016/j.ejogrb.2016.05.023; Welt CK. Autoimmune oophoritis in the adolescent. Ann N Y Acad Sci. 2008;1135:118–122. doi: https://doi.org/10.1196/annals.1429.006; Podfigurna-Stopa A, Czyzyk A, Grymowicz M, et al. Premature ovarian insufficiency: the context of long-term effects.j Endocrinol Invest. 2016;39(9):983–990. doi: https://doi.org/10.1007/s40618-016-0467-z; Luisi S, Orlandini C, Regini C, et al. Premature ovarian insufficiency: from pathogenesis to clinical management.j Endocrinol Invest. 2015;38(6):597–603. doi: https://doi.org/10.1007/s40618-014-0231-1; Akawatcharangura P, Taechakraichana N, Osiri M. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand. Lupus. 2016;25(4):436–444. doi: https://doi.org/10.1177/0961203315617539; Шабанова С.Ш., Ананьева Л.П., Алекберова З.С. Терапия циклофосфаном и овариальная недостаточность у больных системной красной волчанкой // Научно-практическая ревматология. — 2003. — Т. 41. — № 3. — С. 63–67. — doi: https://doi.org/10.14412/1995-4484-2003-1364; Mayorga J, Alpízar-Rodríguez D, Prieto-Padilla J, et al. Prevalence of premature ovarian failure in patients with systemic lupus erythematosus. Lupus. 2016;25(7):675–683. doi: https://doi.org/10.1177/0961203315622824; Юренева С.В., Аверкова В.Г. Вазомоторные симптомы в менопаузе: центральные триггеры, эффекторы и новые возможности патогенетической терапии // Российский вестник акушера-гинеколога. — 2018. — Т. 18. — № 5. — С. 43–48. — doi: https://doi.org/10.17116/rosakush20181805143; Макацария А.Д., Блинов Д.В., Бицадзе В.О., Хизроева Д.Х. Лечение эстриолом вульвовагинальной атрофии в постменопаузе: обновление научных данных 2014–2018 гг. // Акушерство, Гинекология и Репродукция. — 2019. — Т. 13. — № 3. — С. 227–238. — doi: https://doi.org/10.17749/2313-7347.2019.13.227-238; Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18(4):483–491. doi: https://doi.org/10.3109/13697137.2015.1020484; Kalantaridou SN, Calis KA, Vanderhoof VH, et al. Testosterone deficiency in young women with 46,XX spontaneous premature ovarian failure. Fertil Steril. 2006;86(5):1475–1482. doi: https://doi.org/10.1016/j.fertnstert.2006.04.028; Jiao X, Zhang H, Ke H, et al. Premature Ovarian Insufficiency: Phenotypic Characterization Within Different Etiologies.j Clin Endocrinol Metab. 2017;102(7):2281–2290. doi: https://doi.org/10.1210/jc.2016-3960; Кумыкова З.Х., Уварова Е.В., Батырова З.К. Современные подходы к оценке и сохранению овариального резерва у девочек-подростков с преждевременной недостаточностью яичников // Репродуктивное здоровье детей и подростков. — 2022. — Т. 18. — № 3. — С. 34–45. — doi: https://www.doi.org/10.33029/1816-2134-2022-18-3-34-45; Gleicher N, Kushnir VA, Barad DH. Prospectively assessing risk for premature ovarian senescence in young females: a new paradigm. Reprod Biol Endocrinol. 2015;13:34. doi: https://doi.org/10.1186/s12958-015-0026-z; La Marca A, Marzotti S, Brozzetti A, et al. Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles.j Clin Endocrinol Metab. 2009;94(10):3816–3823. doi: https://doi.org/10.1210/jc.2009-0817; Bidet M, Bachelot A, Bissauge E, et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure.j Clin Endocrinol Metab. 2011;96(12):3864–3872. doi: https://doi.org/10.1210/jc.2011-1038; Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106(7):1588–1599. doi: https://doi.org/10.1016/j.fertnstert.2016.09.046; Langrish JP, Mills NL, Bath LE, et al. Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension. 2009;53(5):805–811. doi: https://doi.org/10.1161/HYPERTENSIONAHA.108.126516; Wierman ME, Arlt W, Basson R, et al. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(10):3489–3510. doi: https://doi.org/10.1210/jc.2014-2260; Elias AN, Pandian MR, Rojas FJ. Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls. Gynecol Obstet Invest. 1997;43(1):47–48. doi: https://doi.org/10.1159/000291817; Kalantaridou SN, Braddock DT, Patronas NJ, Nelson LM. Treatment of autoimmune premature ovarian failure. Hum Reprod. 1999;14(7):1777–1782. doi: https://doi.org/10.1093/humrep/14.7.1777; Чернуха Г.Е., Якушевская О.В. Овариальные эффекты витамина D: систематический обзор // Медицинский совет. — 2021. — № 3. — С. 44–49. — doi: https://doi.org/10.21518/2079701X-2021-3-44-49; Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. Washington (DC): National Academies Press (US); 2011. doi: https://doi.org/10.17226/13050; Ling L, Feng X, Wei T, et al. Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats. Stem Cell Res Ther. 2017;8:283. doi: https://doi.org/10.1186/s13287-017-0739-3; Адамян Л.В., Сибирская Е.В., Щерина А.В. Патогенетические аспекты преждевременной недостаточности яичников // Проблемы репродукции. — 2021. — Т. 27. — № 1. — С. 6–12. — doi: https://doi.org/10.17116/repro2021270116; Na J, Kim GJ. Recent trends in stem cell therapy for premature ovarian insufficiency and its therapeutic potential: a review.j Ovarian Res. 2020;13(1):74. doi: https://doi.org/10.1186/s13048-02000671-2; Edessy M, Hosni HN, Shady Y, et al. Autologous stem cells therapy, the first baby of idiopathic premature ovarian failure. AMI. 2016;3(1):19–23. doi: https://doi.org/10.5530/ami.2016.1.7; Кумыкова З.Х., Батырова З.К., Уварова Е.В. Преждевременная недостаточность яичников в раннем репродуктивном возрасте: современные аспекты диагностики и ведения // Репродуктивное здоровье детей и подростков. — 2019. — Т. 15. — № 4. — С. 53–60. — doi: https://doi.org/10.24411/1816-2134-201914006.; https://www.pedpharma.ru/jour/article/view/2648
-
7Academic Journal
Source: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 69, № 6 (2024); 12-20 ; Российский вестник перинатологии и педиатрии; Том 69, № 6 (2024); 12-20 ; 2500-2228 ; 1027-4065
Subject Terms: аутоиммунные заболевания, maternal microchimerism, graft-versus-host disease, autoimmune diseases, материнский микрохимеризм, реакция «трансплантат против хозяина»
File Description: application/pdf
Relation: https://www.ped-perinatology.ru/jour/article/view/2085/1545; Румянцев А.Г., Курцер М.А., Мареева Ю.Б., Мисюрин А.В., Румянцев С.А., Устюгов А.Ю. Клиническое значение материнского микрохимеризма у детей. Клеточная трансплантология и тканевая инженерия 2011; 2: 10–14.; Gammill H.S., Nelson J.L. Naturally acquired microchimerism. Int J Dev Biol 2010; 54: 531–43. DOI:10.1387/ijdb.082767hg; Haig D. Does microchimerism mediate kin conflicts? Chimerism 2014; 5: 53–55. DOI:10.4161/chim.29122; Barba-Müller E., Craddock S., Carmona S., Hoekzema E. Brain plasticity in pregnancy and the postpartum period: links to maternal care giving and mental health. Arch Women’s Ment Health 2019; 22: 289–299. DOI:10.1007/s00737–018–0889-z; Kotler J., Haig D. The temp of human childhood: a maternal foot on the accelerator, a paternal foot on the brake. Evol Anthropol 2018; 27(2): 80–91. DOI:10.1002/evan.21579; Shrivastava S., Naik R., Suryawanshi H., Gupta N.J. Oral Microchimerism: A new concept. Maxillofac Pathol 2019; 23(2): 311. DOI:10.4103/jomfp.JOMFP_85_17; Galofré J.C. Microchimerism in Graves’ disease. J Thyroid Res 2012; 2012: 724382. DOI:10.1155/2012/724382; Fugazzola L., Cirello V., Beck-Peccoz P. Fetal microchimerism as an explanation of disease. Nature Rev Endocrinol 2011; 7: 89–97. DOI:10.1038/nrendo.2010.216; Kara R.J., Bolli P., Karakikes I., Matsunaga I., Tripodi J., Tanweer O. et al. Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res 2012; 110: 82–93. DOI:10.1161/CIRCRESAHA.111.249037; Cómitre-Mariano B., Martínez-García M., García-Gálvez B., Paternina-Die M., Desco M., Carmona S., Victoria Gómez-Gaviro M. Feto-maternal microchimerism: Memories from pregnancy. Review. iScience 2022; 25: 103664 DOI:10.1016/j.isci.2021.103664; Boddy A.M., Fortunato A., Sayres M.W., Aktipis A. Fetal microchimerism and maternal health: a review and evolutionary analysis of cooperation and conflict beyond the womb. BioEssays News Rev Mol Cell Dev Biol 2015; 37: 1106–1118. DOI:10.1002/bies.201500059; Albrecht M., Arck P.C. Vertically transferred immunity in neonates: mothers, mechanisms and mediators. Front Immunol 2020; 11:555/BIBTEX. DOI:10.3389/FIMMU.2020.00555; Kinder J.M., Stelzer I.A., Arck P.C., Way S.S. Immunological implications of pregnancy-induced microchimerism. Nat Rev Immunol 2017; 17(8): 483–494. DOI:10.1038/nri.2017.38; Игнатко И.В., Казбекова М.Т., Якубова Д.И., Силаева Т.М., Родионова А.М. Что мы знаем о фетальном и материнском микрохимеризме? Вопросы гинекологии, акушерства и перинатологии 2021; 20(5): 87–92.; Callender M., Harvill E.T. Maternal vaccination: shaping the neonatal response to pertussis. Front Immunol 2023; 14: 1210580. DOI:10.3389/fimmu.2023.1210580; Balle C., Armistead B., Kiravu A., Song X., Happel A.U., Hoffmann A.A. et al. Factors influencing maternal microchimerism throughout infancy and its impact on infant T cell immunity. J Clin Invest 2022; 132(13): e148826. DOI:10.1172/JCI148826; Панкратьева Л.Л., Мухин В.Е., Володин Н.Н., Румянцев А.Г. Продукция ростовых факторов и цитокинов плодом как прогностический фактор развития легочной гипертензии у глубоконедоношенных детей с бронхолегочной дисплазией. Педиатрия им. Г.Н. Сперанского 2020; 99(1): 65–69.; Waszak M., Cieślik K., Wielgus K., Słomski R., Szalata M., Skrzypczak-Zielińska M. Microchimerism in twins. Arch Med Sci 2013; 9: 1102–1106. DOI:10.5114/aoms.2013.39212; Knippen M.A. Microchimerism: Sharing genes in illness and in health. ISRN Nurs 2011; 2011: 8938. DOI:10.5402/2011/893819; Singh P., Razonable R.R., Lorenz E.C., DiCaudo D.J., Sukov W.R., Bridges A.G. et al. Chronic graft-versus-host disease in pancreas after kidney transplant recipients — An unrecognized entity. Am J Transplant 2021; 21(2): 883–888. DOI:10.1111/ajt.16273; Arias-Ruiz L.F., Contreras-Cárdenas J., Mondragón-Ratkovich P., Ramos-Ibarra M.L., Torres-Bulgarin O. Тrascendencia del microquimerismo fetal en las enfermedades autoinmunes. Rev Biomed 2020; 31(3): 149–158. DOI:10.32776/revbiomed.v31i3.789; Kanaan S.B., Sensoy O., Yan Z., Gadi V.K., Richardson M.L., Nelson J.L. Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism. Proc Natl Acad Sci USA 2019; 116: 201904779. DOI:10.1073/pnas.1904779116; Klonisch Th., Drouin R. Fetal-maternal exchange of multipotent stem/progenitor cells: microchimerism in diagnosis and disease. Trends Mol Med 2009; 15(11): 510–518. DOI:10.1016/j.molmed.2009.09.002; Stevens A.M. Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders? Lupus 2006; 15: 820– 826. DOI:10.1177/0961203306070068; Gammill H.S., Nelson J.L. Naturally acquired microchimerism. Int J Dev Biol 2010; 54(2–3): 531–543. DOI:10.1387/ijdb.082767hg; Broestl L., Rubin J.B., Dahiya S. Fetal microchimerism in human brain tumors. Brain Pathol 2018; 28(4): 484–494. DOI:10.1111/bpa.12557; Hallum S., Jakobsen M.A., Gerds T.A., Pinborg A., Tjønneland A., Kamper-Jørgensen M. Male origin microchimerism and ovarian cancer. Int J Epidemiol 2021; 50(1): 87–94. DOI:10.1093/ije/dyaa019; Kamper-Jørgensen M., Jakobsen M.A., Tjønneland A., SkjøthRasmussen J., Petersen G.L., Hallum S. Male origin microchimerism and brain cancer: a case-cohort study. J Cancer Res Clin Oncol 2023; 149(8): 5469–5474. DOI:10.1007/s00432–022–04494–0; Mahmood U., O’Donoghue K. Microchimeric fetal cells play a role in maternal wound healing after pregnancy. Chimerism 2014; 5: 40–52. DOI:10.4161/chim.28746
-
8Academic Journal
Source: Obstetrics, Gynecology and Reproduction; Vol 18, No 6 (2024); 919-924 ; Акушерство, Гинекология и Репродукция; Vol 18, No 6 (2024); 919-924 ; 2500-3194 ; 2313-7347
Subject Terms: антифосфолипидные антитела, autoimmune diseases, catastrophic antiphospholipid syndrome, CAPS, antiphospholipid antibodies, аутоиммунные заболевания, катастрофический антифосфолипидный синдром, КАФС
File Description: application/pdf
Relation: https://www.gynecology.su/jour/article/view/2293/1285; Shoenfeld Y., Cervera R. Asherson's syndrome of the catastrophic antiphospholipid antibodies. J Rheumatol. 2008;35(10): 2066-8.; Cervera R. Ronald Andrew Asherson. Royal College of Physicians Museum, Inspiring Physicians. 2019;12:5.; Asherson R.A. The catastrophic antiphospholipid (Asherson's) syndrome. Autoimmun Rev. 2006;6(2):64-7. https://doi.org/10.1016/j.autrev.2006.06.005.; Hughes G.R.V. Ron Asherson. Lupus. 2008;17(9):862. https://doi.org/10.1177/0961203308096431.; Asherson R.A., Morgan S.H., Hughes G.R.V. Problems in the rheumatic diseases: lessons from patients. Dordrecht; Boston: Kluwer Academic Publishers, 1988. 211 p.; Cervera R. CAPS Registry. Lupus. 2012;21(7):755-7. https://doi.org/10.1177/0961203312436866.; Denas G., Jose S.P., Bracco A. et al. Antiphospholipid syndrome and the heart: a case series and literature review. Autoimmun Rev. 2014;14(3):214-22. https://doi.Org/10.1016/j.autrev.2014.11.003.; Клименко А.А., Гаффарова А.С., Демидова Н.А. Катастрофический антифосфолипидный синдром: современные аспекты патогенеза, диагностики и лечения. Современная ревматология. 2023;17(3):7— 15. https://doi.org/10.14412/1996-7012-2023-3-7-15.; Комилжанова Д.К. Роль антифосфолипидного синдрома в профилактике невынашивания беременности. Биология и интегративная медицина. 2017;(5):21—6.; Кравченко Е.Н., Гончарова А.А., Куклина Л.В. Состояние новорожденных, родившихся у женщин с антифосфолипидным синдромом, в зависимости от методов его коррекции. Репродуктивное здоровье детей и подростков. 2020;16(1):48-57. https://doi.org/10.33029/1816-2134-2020-16-1-48-57.; Makatsariya A.D., Asherson R.A., Bitsadze V.O. et al. Catastrophic antiphospholipid (Asherson's) syndrome and genetic thrombophilic disorders in obstetrics. Autoimmun Rev. 2006;6(2):89-93. https://doi.org/10.1016/j.autrev.2006.06.011.; Нестерова Э.А., Путилова Н.В. Роль родительско-плодовой тромбофилии в формировании тяжелых форм плацентарной недостаточности. Акушерство и гинекология. 2014;(12):5—9.; https://www.gynecology.su/jour/article/view/2293
-
9Academic Journal
Authors: A. A. Arsenyeva, А. А. Арсеньева
Source: Meditsinskiy sovet = Medical Council; № 2 (2025); 82-90 ; Медицинский Совет; № 2 (2025); 82-90 ; 2658-5790 ; 2079-701X
Subject Terms: метаболический синдром, pathogenesis, skin microbiome, gut microbiome, autoimmune diseases, comorbidity, metabolic syndrome, патогенез, микробиом кожи, микробиом кишечника, аутоиммунные заболевания, коморбидность
File Description: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/8952/7781; Nair PA, Badri T. Psoriasis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available at: https://pubmed.ncbi.nlm.nih.gov/28846344.; Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020;369:m1590. https://doi.org/10.1136/bmj.m1590.; Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med. 2021;21(3):170–173. https://doi.org/10.7861/clinmed.2021-0257.; Кубанов АА, Богданова ЕВ. Эпидемиология псориаза среди населения старше трудоспособного возраста и объемы оказываемой специализированной медицинской помощи больным ПсО в Российской Федерации в 2010–2019 гг. Вестник дерматологии и венерологии. 2020;96(5):7–18. https://doi.org/10.25208/vdv1171-2020-96-5-07-18.; Vojdani A. A Potential Link between Environmental Triggers and Autoimmunity. Autoimmune Dis. 2014;2014:437231. https://doi.org/10.1155/2014/437231.; Liu S, He M, Jiang J, Duan X, Chai B, Zhang J et al. Triggers for the onset and recurrence of psoriasis: a review and update. Cell Commun Signal. 2024;22(1):108. https://doi.org/10.1186/s12964-023-01381-0.; Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–1344. https://doi.org/10.1016/S0140-6736(17)32130-X.; Norlin JM, Löfvendahl S, Schmitt-Egenolf M. Health-related quality of life in patients with generalized pustular psoriasis – a Swedish register study. Ann Med. 2024;56(1):2341252. https://doi.org/10.1080/07853890.2024.2341252.; Логинова ЕЮ, Коротаева ТВ, Корсакова ЮЛ, Губарь ЕЕ, Тремаскина ПО, Василенко ЕА и др. Клинический статус и трудоспособность пациентов, включенных в Общероссийский регистр пациентов с псориатическим артритом. Современная ревматология. 2020;14(3):19–26. https://doi.org/10.14412/1996-7012-2020-3-19-26.; Сон ИМ, Богданова ЕВ. Инвалидность взрослых пациентов со среднетяжелым и тяжелым псориазом в Российской Федерации (по данным Регистра пациентов с псориазом Российского общества дерматовенерологов и косметологов). Современные проблемы здравоохранения и медицинской статистики. 2024;(1):496–510. https://doi.org/10.24412/2312-2935-2024-1-496-510.; Celoria V, Rosset F, Pala V, Dapavo P, Ribero S, Quaglino P, Mastorino L. The Skin Microbiome and Its Role in Psoriasis: A Review. Psoriasis (Auckl). 2023;13:71–78. https://doi.org/10.2147/PTT.S328439.; Spencer SP, Fragiadakis GK, Sonnenburg JL. Pursuing Human-Relevant Gut Microbiota-Immune Interactions. Immunity. 2019;51(2):225–239. https://doi.org/10.1016/j.immuni.2019.08.002.; Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017;76(3):377–390. https://doi.org/10.1016/j.jaad.2016.07.064.; Dand N, Mahil SK, Capon F, Smith CH, Simpson MA, Barker JN. Psoriasis and Genetics. Acta Derm Venereol. 2020;100(3):adv00030. https://doi.org/10.2340/00015555-3384.; Dascălu RC, Bărbulescu AL, Stoica LE, Dinescu ȘC, Biță CE, Popoviciu HV et al. Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis. J Pers Med. 2024;14(5):535. https://doi.org/10.3390/jpm14050535.; Conrad C, Gilliet M. Psoriasis: from Pathogenesis to Targeted Therapies. Clin Rev Allergy Immunol. 2018;54(1):102–113. https://doi.org/10.1007/s12016-018-8668-1.; Ghoreschi K, Balato A, Enerbäck C, Sabat R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet. 2021;397(10275):754–766. https://doi.org/10.1016/S0140-6736(21)00184-7.; Schön MP, Erpenbeck L. The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis. Front Immunol. 2018;9:1323. https://doi.org/10.3389/fimmu.2018.01323.; Abhishek S, Palamadai Krishnan S. Epidermal Differentiation Complex: A Review on Its Epigenetic Regulation and Potential Drug Targets. Cell J. 2016;18(1):1–6. https://doi.org/10.22074/cellj.2016.3980.; Boehncke WH. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences. Front Immunol. 2018;9:579. https://doi.org/10.3389/fimmu.2018.00579.; Garshick MS, Ward NL, Krueger JG, Berger JS. Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week. J Am Coll Cardiol. 2021;77(13):1670–1680. https://doi.org/10.1016/j.jacc.2021.02.009.; Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM et al. Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. Am J Hum Genet. 2015;97(6):816–836. https://doi.org/10.1016/j.ajhg.2015.10.019.; Nanda H, Ponnusamy N, Odumpatta R, Jeyakanthan J, Mohanapriya A. Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing. 3 Biotech. 2020;10(2):43. https://doi.org/10.1007/s13205-019-2038-4.; Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 2009;41(2):199–204. https://doi.org/10.1038/ng.311.; Jordan CT, Cao L, Roberson ED, Pierson KC, Yang CF, Joyce CE et al. PSORS2 is due to mutations in CARD14. Am J Hum Genet. 2012;90(5):784–795. https://doi.org/10.1016/j.ajhg.2012.03.012.; Scudiero I, Zotti T, Ferravante A, Vessichelli M, Vito P, Stilo R. Alternative splicing of CARMA2/CARD14 transcripts generates protein variants with differential effect on NF-κB activation and endoplasmic reticulum stressinduced cell death. J Cell Physiol. 2011;226(12):3121–3131. https://doi.org/10.1002/jcp.22667.; Fuchs-Telem D, Sarig O, van Steensel MA, Isakov O, Israeli S, Nousbeck J et al. Familial pityriasis rubra pilaris is caused by mutations in CARD14. Am J Hum Genet. 2012;91(1):163–170. https://doi.org/10.1016/j.ajhg.2012.05.010.; Kitoh A, Ono M, Naoe Y, Ohkura N, Yamaguchi T, Yaguchi H et al. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity. 2009;31(4):609–620. https://doi.org/10.1016/j.immuni.2009.09.003.; Wong WF, Kohu K, Chiba T, Sato T, Satake M. Interplay of transcription factors in T-cell differentiation and function: the role of Runx. Immunology. 2011;132(2):157–164. https://doi.org/10.1111/j.1365-2567.2010.03381.x.; de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, Dannhauser EN et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet. 2009;41(2):211–215. https://doi.org/10.1038/ng.313.; Riveira-Munoz E, He SM, Escaramís G, Stuart PE, Hüffmeier U, Lee C et al. Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol. 2011;131(5):1105–1109. https://doi.org/10.1038/jid.2010.350.; Queiro R, Morante I, Cabezas I, Acasuso B. HLA-B27 and psoriatic disease: a modern view of an old relationship. Rheumatology. 2016;55(2):221–229. https://doi.org/10.1093/rheumatology/kev296.; Di Meglio P, Villanova F, Nestle FO. Psoriasis. Cold Spring Harb Perspect Med. 2014;4(8):a015354. https://doi.org/10.1101/cshperspect.a015354.; Singh S, Pradhan D, Puri P, Ramesh V, Aggarwal S, Nayek A, Jain AK. Genomic alterations driving psoriasis pathogenesis. Gene. 2019;683:61–71. https://doi.org/10.1016/j.gene.2018.09.042.; Temel B, Adisen E, Gonen S. HLA-Cw6 Status and Treatment Responses Between Psoriasis Patients. Indian J Dermatol. 2021;66(6):632–637. https://doi.org/10.4103/ijd.IJD_282_21.; Dand N, Stuart PE, Bowes J, Ellinghaus D, Nititham J, Saklatvala JR et al. GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. Nat Commun. 2025;16(1):2051. https://doi.org/10.1038/s41467-025-56719-8.; Gao Z, Tseng CH, Strober BE, Pei Z, Blaser MJ. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE. 2008;3(7):e2719. https://doi.org/10.1371/journal.pone.0002719.; Fahlén A, Engstrand L, Baker BS, Powles A, Fry L. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res. 2012;304(1):15–22. https://doi.org/10.1007/s00403-011-1189-x.; Alekseyenko AV, Perez-Perez GI, De Souza A, Strober B, Gao Z, Bihan M et al. Community differentiation of the cutaneous microbiota in psoriasis. Microbiome. 2013;1(1):31. https://doi.org/10.1186/2049-2618-1-31.; Chang HW, Yan D, Singh R, Liu J, Lu X, Ucmak D et al. Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization. Microbiome. 2018;6(1):154. https://doi.org/10.1186/s40168-018-0533-1.; Tett A, Pasolli E, Farina S, Truong DT, Asnicar F, Zolfo M et al. Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis. NPJ Biofilms Microbiomes. 2017;3:14. https://doi.org/10.1038/s41522-017-0022-5.; Fyhrquist N, Muirhead G, Prast-Nielsen S, Jeanmougin M, Olah P, Skoog T et al. Microbe-host interplay in atopic dermatitis and psoriasis. Nat Commun. 2019;10(1):4703. https://doi.org/10.1038/s41467-019-12253-y.; Quan C, Chen XY, Li X, Xue F, Chen LH, Liu N et al. Psoriatic lesions are characterized by higher bacterial load and imbalance between Cutibacterium and Corynebacterium. J Am Acad Dermatol. 2020;82(4):955–961. https://doi.org/10.1016/j.jaad.2019.06.024.; Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk Factors for the Development of Psoriasis. Int J Mol Sci. 2019;20(18):4347. https://doi.org/10.3390/ijms20184347.; Vijaya Chandra SH, Srinivas R, Dawson TLJr, Common JE. Cutaneous Malassezia: Commensal, Pathogen, or Protector? Front Cell Infect Microbiol. 2021;10:614446. https://doi.org/10.3389/fcimb.2020.614446.; Kanda N, Tani K, Enomoto U, Nakai K, Watanabe S. The skin fungus-induced Th1- and Th2-related cytokine, chemokine and prostaglandin E2 production in peripheral blood mononuclear cells from patients with atopic dermatitis and psoriasis vulgaris. Clin Exp Allergy. 2002;32(8):1243–1250. https://doi.org/10.1046/j.1365-2745.2002.01459.x.; Gomez-Moyano E, Crespo-Erchiga V, Martínez-Pilar L, Godoy Diaz D, Martínez-García S, Lova Navarro M, Vera Casaño A. Do Malassezia species play a role in exacerbation of scalp psoriasis? J Mycol Med. 2014;24(2):87–92. https://doi.org/10.1016/j.mycmed.2013.10.007.; Fabisiak A, Murawska N, Fichna J. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity. Pharmacol Rep. 2016;68(4):802–808. https://doi.org/10.1016/j.pharep.2016.03.015.; Sikora M, Stec A, Chrabaszcz M, Knot A, Waskiel-Burnat A, Rakowska A et al. Gut Microbiome in Psoriasis: An Updated Review. Pathogens. 2020;9(6):463. https://doi.org/10.3390/pathogens9060463.; Visser MJE, Kell DB, Pretorius E. Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris. Front Cell Infect Microbiol. 2019;9:7. https://doi.org/10.3389/fcimb.2019.00007.; Chen YJ, Ho HJ, Tseng CH, Lai ZL, Shieh JJ, Wu CY. Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients. Exp Dermatol. 2018;27(12):1336–1343. https://doi.org/10.1111/exd.13786.; Codoñer FM, Ramírez-Bosca A, Climent E, Carrión-Gutierrez M, Guerrero M, Pérez-Orquín JM et al. Gut microbial composition in patients with psoriasis. Sci Rep. 2018;8(1):3812. https://doi.org/10.1038/s41598-018-22125-y.; Huang L, Gao R, Yu N, Zhu Y, Ding Y, Qin H. Dysbiosis of gut microbiota was closely associated with psoriasis. Sci China Life Sci. 2019;62(6):807–815. https://doi.org/10.1007/s11427-018-9376-6.; Shapiro J, Cohen NA, Shalev V, Uzan A, Koren O, Maharshak N. Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls. J Dermatol. 2019;46(7):595–603. https://doi.org/10.1111/1346-8138.14933.; Zákostelská Z, Málková J, Klimešová K, Rossmann P, Hornová M, Novosádová I et al. Intestinal Microbiota Promotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response. PLoS ONE. 2016;11(7):e0159539. https://doi.org/10.1371/journal.pone.0159539.; Stehlikova Z, Kostovcikova K, Kverka M, Rossmann P, Dvorak J, Novosadova I et al. Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model. Front Microbiol. 2019;10:236. https://doi.org/10.3389/fmicb.2019.00236.; Gisondi P, Fostini AC, Fossà I, Girolomoni G, Targher G. Psoriasis and the metabolic syndrome. Clin Dermatol. 2018;36(1):21–28. https://doi.org/10.1016/j.clindermatol.2017.09.005.; Bellinato F, Maurelli M, Geat D, Girolomoni G, Gisondi P. Managing the Patient with Psoriasis and Metabolic Comorbidities. Am J Clin Dermatol. 2024;25(4):527–540. https://doi.org/10.1007/s40257-024-00857-0.; Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. 2012;132(3):556–562. https://doi.org/10.1038/jid.2011.365.; Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013;68(4):654–662. https://doi.org/10.1016/j.jaad.2012.08.015.; Tablazon IL, Al-Dabagh A, Davis SA, Feldman SR. Risk of cardiovascular disorders in psoriasis patients: current and future. Am J Clin Dermatol. 2013;14(1):1–7. https://doi.org/10.1007/s40257-012-0005-5.; Phan C, Sigal ML, Lhafa M, Barthélémy H, Maccari F, Estève E et al. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases. Ann Dermatol Venereol. 2016;143(4):264–274. https://doi.org/10.1016/j.annder.2015.06.024.; Hu MY, Yang Q, Zheng J. The association of psoriasis and hypertension: focusing on anti-inflammatory therapies and immunological mechanisms. Clin Exp Dermatol. 2020;45(7):836–840. https://doi.org/10.1111/ced.14327.; Lin Z, Shi YY, Yu LY, Ma CX, Pan SY, Dou Y et al. Metabolic dysfunction associated steatotic liver disease in patients with plaque psoriasis: a casecontrol study and serological comparison. Front Med (Lausanne). 2024;11:1400741. https://doi.org/10.3389/fmed.2024.1400741.; Brownstein MH. Psoriasis and diabetes mellitus. Arch Dermatol. 1966;93(6): 654–655. https://doi.org/10.1001/archderm.1966.01600240020003.; Binazzi M, Calandra P, Lisi P. Statistical association between psoriasis and diabetes: further results. Arch Dermatol Res. 1975;254(1):43–48. https://doi.org/10.1007/BF00561533.; Yuan Z, Guo Y. Risk of incident type 2 diabetes in patients with psoriatic arthritis: A systematic review and meta-analysis of cohort studies. Int J Rheum Dis. 2022;25(9):1029–1037. https://doi.org/10.1111/1756-185X.14375.; Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347:f5961. https://doi.org/10.1136/bmj.f5961.; Ungprasert P, Raksasuk S. Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(7):1277–1283. https://doi.org/10.1007/s11255-018-1868-z.; Duan K, Wang J, Chen S, Chen T, Wang J, Wang S, Chen X. Causal associations between both psoriasis and psoriatic arthritis and multiple autoimmune diseases: a bidirectional two-sample Mendelian randomization study. Front Immunol. 2024;15:1422626. https://doi.org/10.3389/fimmu.2024.1422626.
-
10Academic Journal
Authors: G. I. Gridneva, B. S. Belov, E. S. Aronova, Г. И. Гриднева, Б. С. Белов, Е. С. Аронова
Contributors: Статья подготовлена в рамках научно-исследовательской работы ФГБНУ «Научно-исследовательский институт ревматологии им. В. А. Насоновой», № государственного задания 1021051503137–7.
Source: HIV Infection and Immunosuppressive Disorders; Том 17, № 1 (2025); 7-18 ; ВИЧ-инфекция и иммуносупрессии; Том 17, № 1 (2025); 7-18 ; 2077-9828 ; 10.22328/2077-9828-2025-17-1
Subject Terms: артрит, rheumatic diseases, autoimmune diseases, arthritis, ревматические заболевания, аутоиммунные заболевания
File Description: application/pdf
Relation: https://hiv.bmoc-spb.ru/jour/article/view/979/622; ВИЧ-инфекция у взрослых. Клинические рекомендации 2024. https://cr.minzdrav.gov.ru/schema/79_2.; ВИЧ-инфекция в Российской Федерации на 30 июня 2023 г. Специализированный научно-исследовательский отдел по профилактике и борьбе со СПИДом ФБУН Центрального НИИ эпидемиологии Роспотребнадзора. . https://files.antispidnn.ru/uploads/docs/spec/vich2023.pdf.; Steve R.J., Alex D., Yesudhason B.L. et al. Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It // Current HIV research. 2021. Vol. 19, No. 3. Р. 277–285. https://doi.org/10.2174/1570162X19666210217120337.; Zandman-Goddard G., Shoenfeld Y. HIV and autoimmunity // Autoimmunity reviews. 2002. Vol. 1, No. 6. P. 329–337. https://doi.org/10.1016/s1568-9972(02)00086-1.; Fox C., Walker-Bone K. Evolving spectrum of HIV-associated rheumatic syndromes. Best practice research // Clinical rheumatology. 2015. Vol. 29, No. 2. P. 244–258. https://doi.org/10.1016/j.berh.2015.04.019.; Ramos-Ruperto L., Busca C., Díez-Vidal A. et al. Prevalence and Temporal Trends of Autoimmune Diseases in People Living with HIV // AIDS Res. Hum. Retroviruses. 2023 Mar; Vol. 39, No. 3. Р. 130–135. doi:10.1089/AID.2022.0090.; Ramos-Ruperto L. et al. Autoimmunity and HIV infection. Chapter 7 // Translational Autoimmunity. Vol. 3. Р. 141. https://doi.org/10.1016/B978-0-323-85415-3.00015-5.; Evans R., Gueret-Wardle A., Edwards S., Salama A. ANCA-associated vasculitis and pauci-immune glomerulonephritis in HIV disease // BMJ case reports 2014. P. 1–3. Published online 1 April 2014. https://doi.org/10.1136/bcr-2013-202423.; Mirsaeidi M., Syed F., Jaffe E.S. Antineutrophil Cytoplasmic Autoantibody Associated Systemic Vasculitis Is Associated with Epstein–Barr virus in the Setting of HIV Infection // Infectious diseases in clinical practice (Baltimore, Md.). 2013. Vol. 21, No. 1. P. 50–53. https://doi.org/10.1097/IPC.0b013e3182601ea1.; Savige J.A., Chang L., Horn S., Crowe S.M. Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals // Autoimmunity. 1994. Vol. 18, No. 3. P. 205–211. https://doi.org/10.3109/08916939409007997; Mohapatra P. R., Khanduri S., Dutt N., Sharma P., Janmeja A. K. Diagnostic dilemma of antineutrophil cytoplasmic antibody seropositivity in human immunodeficiency virus infection // The Indian journal of chest diseases allied sciences. 2011. Vol. 53, No. 1. P. 55–57.; Gherardi R., Belec L., Mhiri C. et al. The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation // Arthritis and rheumatism. 1993. Vol. 36, No. 8. P. 1164–1174. https://doi.org/10.1002/art.1780360818.; Bottlaender L., Sève P., Cotte L., Gerfaud-Valentin M., Jamilloux Y. Successful treatment with anakinra of an HIV-associated immune reconstitution inflammatory syndrome mimicking adult-onset Still’s disease // Rheumatology (Oxford, England). 2019. Vol. 58, No. 2. P. 363–365. https://doi.org/10.1093/rheumatology/key291.; Российские клинические рекомендации. Ревматология / под ред. Е. Л. Насонова. М.: ГЭОТАР-Медиа, 2017. С. 113; Akram B., Khan M., Humphrey M.B. HIV-Associated Rheumatic Diseases: A Narrative Review // Journal of clinical rheumatology: practical reports on rheumatic musculoskeletal diseases. 2024. Vol. 30, No. 2. P. e42–e45. https://doi.org/10.1097/RHU.0000000000002028.; Lebrun D., Hentzien M., Cuzin L. et al.; the Dat’AIDS study group. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort // AIDS. 2017. Sep 24; Vol. 31, No. 15. Р. 2159–2166. doi:10.1097/QAD.0000000000001603.; Kawakita C., Kinomura M., Otaka N. et al. HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy // Internal medicine (Tokyo, Japan). 2019. Vol. 58, No. 20. P. 3001–3007. https://doi.org/10.2169/internalmedicine.2439-18.; Naovarat B.S., Reveille J.D., Salazar G.A., William F.M., Nguyen B.Y. Systemic lupus erythematosus in the setting of HIV-1 infection: a longitudinal analysis // Clinical rheumatology. 2020. Vol. 39, No. 2. P. 413–418. https://doi.org/10.1007/s10067-019-04867-w.; Torgashina A.V., Solovyev S.K. Specific features of regulatory T cells in patients with systemic lupus erythematosus // Modern Rheumatology Journal. 2018. Vol. 12, No. 4. P. 9–15. doi:10.14412/1996-7012-2018-4-9-15.; Liao H.Y., Tao C.M., Su J. Concomitant systemic lupus erythematosus and HIV infection: A rare case report and literature review // Medicine. 2017. Vol. 96, No. 51. P. e9337. https://doi.org/10.1097/MD.0000000000009337.; O’Kelly B., McNally C., McConkey S., Durcan L. HIV and systemic lupus erythematosus: where immunodeficiency meets autoimmunity // Lupus. 2020. Vol. 29, No. 9. P. 1130–1132. https://doi.org/10.1177/0961203320934851.; Российские клинические рекомендации. Ревматология / под ред. Е. Л. Насонова. М.: ГЭОТАР-Медиа, 2020. С. 17; Smolen J.S., Aletaha D., McInnes I.B. Rheumatoid arthritis // Lancet (London, England). 2016. Vol. 388, No. 10055. P. 2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8.; Reveille J.D., Williams F.M. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best practice and research // Clinical rheumatology. 2006. Vol. 20, No. 6. P. 1159–1179. https://doi.org/10.1016/j.berh.2006.08.015.; Буханова Д.В., Белов Б.С. Поражение суставов при ВИЧ-инфекции // Медицинский cовет. 2018. № 9. C. 82–87; Hanberg J.S., Hsieh E., Akgün K.M., Weinstein E., Fraenkel L., Justice A.C., VACS Project Team. Incident Rheumatoid Arthritis in HIV Infection: Epidemiology and Treatment // Arthritis rheumatology (Hoboken N.J.). 2021. Vol. 73, No. 12. P. 2189–2199. https://doi.org/10.1002/art.41802.; Cunha B.M., Mota L.M., Pileggi G.S., Safe I.P., Lacerda M.V. HIV/AIDS and rheumatoid arthritis // Autoimmunity reviews. 2015. Vol. 14, No. 5. P. 396–400. https://doi.org/10.1016/j.autrev.2015.01.001.; Azeroual A., Harmouche H., Benjilali L. et al. Rheumatoid arthritis associated to HIV infection // European journal of internal medicine. 2008. Vol. 19, No. 6. P. e34–e35. https://doi.org/10.1016/j.ejim.2007.09.020.; Mariette X., Criswell L.A. Primary Sjögren’s Syndrome // The New England journal of medicine. 2018. Vol. 378, No. 10. P. 931–939. https://doi.org/10.1056/NEJMcp1702514.; Ghrenassia E., Martis N., Boyer J. et al. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review // Journal of autoimmunity. 2015. No. 59, P. 19–25. https://doi.org/10.1016/j.jaut.2015.01.010.; Yang J.J., Tsai M.S., Sun H.Y. et al. Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy // Journal of microbiology, immunology, and infection=Wei mian yu gan ran za zhi. 2015. Vol. 48, No. 2. P. 130–136. https://doi.org/10.1016/j.jmii.2013.08.002.; Каневская М.З. Ревматологические синдромы при ВИЧ-инфекции // Клиническая медицина. 2014. T. 92, № 12. C. 12–19.; McArthur C.P., Africa C.W., Castellani W.J. et al. Salivary gland disease in HIV/AIDS and primary Sjögren’s syndrome: analysis of collagen I distribution and histopathology in American and African patients // Journal of oral pathology medicine: official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2003. Vol. 32, No. 9. P. 544–551. https://doi.org/10.1034/j.1600-0714.2003.00159.x.; Saigal R., Chakraborty A., Yadav R.N., Goyal L.K. Rheumatological Manifestations in HIV-Positive Patients: A Single-Center Study // Advances in therapy. 2020. Vol. 37, No. 10. P. 4336–4345. https://doi.org/10.1007/s12325-020-01470-3.; Kordossis T., Paikos S., Aroni K. et al. Prevalence of Sjögren’s-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology // British journal of rheumatology. 1998. Vol. 37, No. 6. P. 691–695. https://doi.org/10.1093/rheumatology/37.6.691; Kuvardin E.S., Grigor’yeva I.N., Bekhtereva I.A., Maslyansky A.L., Krivolapov Yu.A., Belyakova E.A. Cellular composition of the minor salivary gland inflammatory infiltrates as an additional diagnostic criterion for primary Sjogren’s syndrome // Rheumatology Science and Practice. 2021. Vol. 59, No. 4. P. 434–441 (In Russ.)]. https://doi.org/10.47360/1995-4484-2021-434-441.; Российские клинические рекомендации. Ревматология / под ред. Е. Л. Насонова. М.: ГЭОТАР-Медиа, 2020. 182 с.; Vega L.E., Espinoza L.R. Vasculitides in HIV Infection // Current rheumatology reports. 2020. Vol. 22, No. 10. P. 60. https://doi.org/10.1007/s11926-020-00945-0.; Zhang X., Li H., Li T., Zhang F., Han Y. Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in China // The Journal of rheumatology. 2007. Vol. 34, No. 8. P. 1760–1764.; Vornicu A., Obrișcă B., Sorohan B., Berechet A., Ismail G. ANCA-associated vasculitis in a HIV-infected patient:a case-based review // BMC nephrology. 2023. Vol. 24, No. 1. P. 210. https://doi.org/10.1186/s12882-023-03244-9.; De Paoli M.C., Moretti D., Scolari Pasinato C.M., Buncuga M.G. Púrpura de Schönlein-Henoch en adulto HIV positivo adicto a cocaína y ANCAp positivo . Spanish Medicina. 2016. Vol. 76, No. 4. P. 245–248.; Monteiro E.J., Caron D., Balda C.A. et al. Anti-glomerular basement membrane glomerulonephritis in an HIV positive patient: case report // The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases. 2006. Vol. 10, No. 1. P. 55–58. https://doi.org/10.1590/s1413-86702006000100011.; Maharaj A.B. Rheumatoid arthritis and HIV-associated arthritis: Two sides of the same coin or different coins. Best practice research // Clinical rheumatology. 2022. Vol. 36, No. 1. P. 101739. https://doi.org/10.1016/j.berh.2021.101739.; Mody G.M., Parke F.A., Reveille, J.D. Articular manifestations of human immunodeficiency virus infection // Best practice and research // Clinical rheumatology. 2003. Vol. 17, No. 2. P. 265–287. https://doi.org/10.1016/s1521-6942(03)00003-2.; Lawson E., Walker-Bone K. The changing spectrum of rheumatic disease in HIV infection // British medical bulletin. 2012. Vol. 103, No. 1. P. 203–221. https://doi.org/10.1093/bmb/lds022.; Круглова Л.С., Переверзина Н.О. Риски инфекционных заболеваний у пациентов с псориазом кожи, принимающих генно-инженерные препараты: данные собственного исследования // Эффективная фармакотерапия. 2024. Т. 20, No. 1. С. 6–16. doi:10.33978/2307-3586-2024-20-1-6-16.; Ceccarelli M., Venanzi Rullo E., Vaccaro M. et al. HIV-associated psoriasis: Epidemiology, pathogenesis, and management // Dermatologic therapy. 2019. Vol. 32, No. 2. P. e12806. https://doi.org/10.1111/dth.12806.; Fink D.L., Hedley L., Miller R.F. Systematic review of the efficacy and safety of biological therapy for inflammatory conditions in HIV-infected individuals // International journal of STD AIDS. 2017. Vol. 28, No. 2. P. 110–119. https://doi.org/10.1177/0956462416675109.; Nakamura M., Abrouk M., Farahnik B., Zhu T. H., Bhutani T. Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies // Cutis. 2018. Vol. 101, No. 1. P. 38–56.; Alpalhão M., Borges-Costa J., Filipe P. Psoriasis in HIV infection: an update // International journal of STD AIDS. 2019. Vol. 30, No. 6. P. 596– 604. https://doi.org/10.1177/0956462419827673.; Гриднева Г.И., Белов Б.С. Актуальные вопросы ведения пациентов с ВИЧ-инфекцией и ревматическими заболеваниями // Современная ревматология. 2021. Т. 15, № 6. C. 7–12. https://doi.org/10.14412/1996-7012-2021-6-7-12.; Елисеева М.Е., Елисеев М.С. Значение гиперурикемии в развитии заболеваний человека и методы ее коррекции // Доктор. Ру. 2019. Т. 2, № 157. С. 47–54. doi:10.31550/1727-2378-2019-157-2-47-54.; Creighton S., Miller R., Edwards S., Copas A., French P. Is ritonavir boosting associated with gout? // International journal of STD AIDS. 2005. Vol. 16, No. 5. P. 362–364. https://doi.org/10.1258/0956462053888907.; Nicholson P., Saunsbury E., D’Angelo S., Churchill D., Walker-Bone K. Prevalence of and risk factors for gout in HIV-positive adults: A casecontrol study // International journal of STD AIDS. 2019. Vol. 30, No. 3. P. 249–255. https://doi.org/10.1177/0956462418799803.; Afzal W., Wali O.M., Cervellione K.L., Singh B.B., Bagheri F. Coexistent Pseudogout and Mycobacterium avium-intracellulare Septic Arthritis in a Patient with HIV and ESRD // Case reports in rheumatology. 2016. 5495928. https://doi.org/10.1155/2016/5495928.; Hanberg J.S., Akgün K.M., Hsieh E., Fraenkel L., Justice A.C. Incidence and Presentation of Sarcoidosis With and Without HIV Infection // Open forum infectious diseases. 2020. Vol. 7, No. 10. ofaa441. https://doi.org/10.1093/ofid/ofaa441.; Foulon G., Wislez M., Naccache J. M. et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy // Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2004. Vol. 38, No. 3. P. 418–425. https://doi.org/10.1086/381094.; Trevenzoli M., Cattelan A.M., Marino F., Marchioro U., Cadrobbi P. Sarcoidosis and HIV infection: a case report and a review of the literature // Postgraduate medical journal. 2003. Vol. 79, No. 935. P. 535–538. https://doi.org/10.1136/pmj.79.935.535.; Ibrahim I.A., Estaitieh O.M., Alrabee H.A., Alzahrani M. Sarcoidosis and HIV infection in a native Saudi man // BMJ case reports. 2018. bcr2018224386. https://doi.org/10.1136/bcr-2018-224386.; Adizie T., Moots R.J., Hodkinson B., French N., Adebajo A.O. Inflammatory arthritis in HIV positive patients: A practical guide // BMC infectious diseases. 2016. No. 16. Р. 100. https://doi.org/10.1186/s12879-016-1389-2.; Packham J., Arkell P., Sheeran T., Brownfield A., Cadwgan A., Ryan, S. Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication: a quantitative study // Clinical rheumatology. 2017. Vol. 36, No. 11. P. 2595–2600. https://doi.org/10.1007/s10067-017-3642-5.; Pangilinan M. C. G., Sermswan P., Asawanonda P. Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis // Case reports in dermatology. 2020. Vol. 12, No. 2. P. 132–137. https://doi.org/10.1159/000508781.; Di Lernia V., Casanova D. M., Garlassi E. Secukinumab in an HIV-positive patient with psoriasis // Journal der Deutschen Dermatologischen Gesellschaft=Journal of the German Society of Dermatology: JDDG. 2019. Vol. 17, No. 6. P. 646–648. https://doi.org/10.1111/ddg.13851.; Bartos G., Cline A., Beroukhim K., Burrall B. A., Feldman S. R. Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review // Dermatology online journal. 2018. Vol. 24, No. 11. 13030/qt3db748cg.; Paparizos V., Rallis E., Kirsten L., Kyriakis K. Ustekinumab for the treatment of HIV psoriasis // The Journal of dermatological treatment. 2012. Vol. 23, No. 6. P. 398–399. https://doi.org/10.3109/09546634.2011.579085.; Saeki H., Ito T., Hayashi M. et al. Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection // Journal of the European Academy of Dermatology and Venereology: JEADV. 2015. Vol. 29, No. 8. P. 1653–1655. https://doi.org/10.1111/jdv.12531.; Bardazzi F., Magnano M., Campanati A. et al. Biologic Therapies in HIV-infected Patients with Psoriasis: An Italian Experience // Acta dermato- venereologica. 2017. Vol. 97, No. 8. P. 989–990. https://doi.org/10.2340/00015555-2698.; Wang D.M., Fernandez A.P., Calabrese C.M., Calabrese L.H. Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma // Clinical and experimental dermatology. 2019. Vol. 44, No. 1. P. 113–115. https://doi.org/10.1111/ced.13630.; Cepeda E.J., Williams F.M., Ishimori M.L. et al. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease // Annals of the rheumatic diseases. 2008. Vol. 67, No. 5. P. 710–712. https://doi.org/10.1136/ard.2007.081513.; Wangsiricharoen S., Ligon C., Gedmintas L. et al. Rates of Serious Infections in HIV-Infected Patients Receiving Tumor Necrosis Factor Inhibitor Therapy for Concomitant Autoimmune Diseases // Arthritis care research. 2017. Vol. 69, No. 3. P. 449–452. https://doi.org/10.1002/acr.22955.; Narcisi A., Bernardini N., Orsini D. et al. Long-term safety and efficacy of adalimumab in psoriasis: a multicentric study focused on infections (connecting study) // Postepy dermatologii i alergologii. 2020. Vol. 37, No. 3. P. 428–434. https://doi.org/10.5114/ada.2020.96910.; Liang S.J., Zheng Q.Y., Yang Y. L. et al. Use of etanercept to treat rheumatoid arthritis in an HIV-positive patient: a case-based review // Rheumatology international. 2017. Vol. 37, No. 7. P. 1207–1212. https://doi.org/10.1007/s00296-017-3690-9.; Marcelin A.G., Aaron L., Mateus C. et al. Rituximab therapy for HIV-associated Castleman disease // Blood. 2003. Vol. 102, No. 8. P. 2786– 2788. https://doi.org/10.1182/blood-2003-03-0951.; Zalmanovich A., Ben-Ami R., Rahav G. et al. Rituximab identified as an independent risk factor for severe PJP: A case-control study // PloS Оne. 2020. Vol. 15, No. 9. P. e0239042. https://doi.org/10.1371/journal.pone.0239042.; Habbous S., Guo H., Beca J. et al. The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B-cell lymphoma // Cancer medicine. 2020. Vol. 9, No. 19. P. 7072–7082. https://doi.org/10.1002/cam4.3362.; Hoff P., Walther M., Wesselmann H. et al. Erfolgreiche Behandlung eines adulten Morbus Still mit Tofacitinib bei einer HIV-2-positiven Patientin [Successful treatment of adult Still’s disease with tofacitinib in a HIV-2 positive female patient] // Zeitschrift fur Rheumatologie. 2020. Vol. 79, No. 10. P. 1046–1049. https://doi.org/10.1007/s00393-020-00853-9.
-
11Academic Journal
-
12Academic Journal
-
13Academic Journal
Source: Мать и дитя в Кузбассе, Vol 25, Iss 4, Pp 65-71 (2024)
-
14Academic Journal
Authors: Guţu, I.A., Bacinschi, N.G., Bachinsky, N., Caracaş, A., Cernelev, V.
Source: Sănătate Publică, Economie şi Management în Medicină 102 (5) 126-132
Subject Terms: glucocorticoizi, глюкокортикоиды, farmacocinetica, naştere prematură, preterm birth, boli autoimune, sarcina, fertilitate, Fertility, аутоиммунные заболевания, Фертильность, Pharmacokinetics, autoimmune diseases, pregnancy, фармакокинетика, Glucocorticoids, преждевременные роды, беременность
File Description: application/pdf
Access URL: https://ibn.idsi.md/vizualizare_articol/215784
-
15Academic Journal
Source: Scientific and practical specialized journal "Rheumatology of Kazakhstan". :113-116
Subject Terms: immunoblot, ANF, аутоиммунные заболевания, autoimmune diseases, иммуноблот, АНФ, NRIF-Hep, 3. Good health, НРИФ-HЕp
-
16Academic Journal
Authors: Г. Э. , Тулакова, Ш. Ш. , Байлатова
Source: World of Medicine : Journal of Biomedical Sciences; Vol. 1 No. 9 (2024): World of Medicine : Journal of Biomedical Sciences; 61-64 ; 2960-9356
Subject Terms: факоэмульсификация катаракты, системные и ревматические аутоиммунные заболевания, увеальная катаракта
File Description: application/pdf
-
17Academic Journal
Authors: Назарова, А. Б.
Source: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 12 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 34-39 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 12 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 34-39 ; 2181-3469
Subject Terms: аутоиммунные заболевания щитовидной железы, аутоиммунные полигландулярные синдромы, мультиорганный аутоиммунный синдром
File Description: application/pdf
-
18Academic Journal
Authors: Назарова, А. Б.
Source: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 10 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 123-128 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 10 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 123-128 ; 2181-3469
Subject Terms: аутоиммунные заболевания щитовидной железы, аутоиммунные полигландулярные синдромы, мультиорганный аутоиммунный синдром
File Description: application/pdf
-
19Academic Journal
Authors: Маликовна, Ахмедова Шахло
Source: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 4 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 87-89 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 4 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 87-89 ; 2181-3469
Subject Terms: Сахарный диабет, метаболизма углеводов, СД 2 типа, аутоиммунные заболевания щитовидной железы
File Description: application/pdf
-
20Academic Journal
Source: SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES; Vol. 3 No. 3 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 216-220 ; НАУЧНЫЙ ЖУРНАЛ ПРИКЛАДНЫХ И МЕДИЦИНСКИХ НАУК; Том 3 № 3 (2024): AMALIY VA TIBBIYOT FANLARI ILMIY JURNALI; 216-220 ; 2181-3469
Subject Terms: Витамин D, Дефицит витамина D, Заболевания у детей, Рахит, Иммунная система, Профилактика дефицита витамина D, Аутоиммунные заболевания
File Description: application/pdf